Dna X (SONM) Accounts Payables (2018 - 2026)

Dna X has reported Accounts Payables for 9 years, with the latest figure at $719000.0 in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables fell 95.84% year-over-year to $719000.0; the trailing twelve-month figure through Mar 2026 stood at $719000.0 (down 95.84% YoY), and the FY2025 full-year result was $4.0 million, up 446.07% from the prior year.
• Accounts Payables for Q1 2026 stood at $719000.0, down from $4.0 million in the prior quarter.
• The five-year high for Accounts Payables was $23.3 million in Q3 2023, with the low at $719000.0 in Q1 2026.
• Historically, Accounts Payables has averaged $13.6 million across 5 years, with a median of $13.4 million in 2022.
• Annual changes were most pronounced in 2024 — Accounts Payables plunged 96.28% — and 2025, when it surged 446.07%.
• Dna X's Accounts Payables stood at $21.1 million in 2022, then slipped by 6.05% to $19.8 million in 2023, then sank by 96.28% to $738000.0 in 2024, then surged by 446.07% to $4.0 million in 2025, then plunged by 82.16% to $719000.0 in 2026.
• The last three Accounts Payables figures came in at $719000.0 (Q1 2026), $4.0 million (Q4 2025), and $20.4 million (Q3 2025), per Business Quant data.